Search is Powered by Google
Cancer / Oncology News

How To Move Cancer Research Forward: Public/Private Partnerships - A NCI Science Writer's Seminar

Main Category: Cancer / Oncology
Also Included In: Conferences
Article Date: 02 Jul 2008 - 1:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts
What
br> Please join us for a science writers' seminar to discuss public/private partnerships in cancer research. Among the topics discussed will be working with industry to develop new drugs; cancer vaccine development and business barriers; working with small businesses to develop new technologies to catch cancer in its earliest stages; and intellectual property rights and technology transfer issues related to new genetic tests. The seminar will be in a classroom setting with ample time for Q&A and interaction during the talks.

Who

Leading experts from the National Cancer Institute (NCI), including:

John E. Niederhuber, M.D., Director
James Doroshow, M.D., Director, Division of Cancer Treatment and Diagnosis
Jeffrey Schlom, Ph.D., Chief, Laboratory of Tumor Immunology and Biology
Michael Weingarten, M.A., Director, Small Business Programs
Karen Maurey, M.A., Director, Technology Transfer Center
Jason Cristofaro, Ph.D., J.D., Intellectual Property Advisor

When

Monday, July 28, 2008: 8:45 a.m. - 11:30 a.m. (EDT)
Registration will be at 8:45 a.m. Talks by experts will begin at 9:00 a.m. A coffee break will occur about 10:15 a.m.

Where

NIH, Natcher Conference Center, Rooms F1/F2
9000 Rockville Pike, Bethesda, Md.
Attendees are strongly encouraged to use the Metro. The NIH campus can be easily accessed via the Medical Center stop on the Metro's Red Line. For transportation, parking and security at NIH, go to http://www.nih.gov/about/visitorsecurity.htm.

How

Please register for the seminar by contacting the NCI Office of Media Relations at (301) 496-6641 or ncipressofficers@mail.nih.gov.

National Cancer Institute




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...